Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients

August 25, 2017 updated by: Lawson Health Research Institute

Evaluation of a Liberal Versus Restrictive Blood Transfusion Strategy in Elderly Patients Following Coronary Bypass or Aortic Valve Surgery

The purpose of this study is to determine whether a less restrictive strategy of red blood cell transfusion in elderly patients following coronary bypass surgery results in enhanced postoperative recovery as determined by quality of life assessment, exercise tolerance and clinical outcomes.

Two postoperative transfusion strategies:

  1. Liberal - transfused when Hgb is <100g/L
  2. Restrictive - transfused when Hgb is <70g/L

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6A 5A5
        • London Health Sciences Centre - University Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years to 90 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients >=70 years of age undergoing non-emergency coronary artery bypass surgery
  • Initial postoperative hemoglobin level 70-90g/L

Exclusion Criteria:

  • Patients who are unable to provide informed consent in English
  • Patients with preoperative hemoglobin concentrations <100g/L
  • Patients who require emergency re-operation
  • Patients with intraoperative or postoperative bleeding diathesis
  • Patients with postoperative clinical instability (eg. low output state)
  • Patients in whom insertion of an intra-aortic balloon pump is required

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Liberal Red cell transfusion arm
Transfusion if Hgb <100g/L
Blood transfusion will be administered when the transfusion trigger is met.
Active Comparator: Restrictive Red Cell transfusion
Transfusion if Hgb <70g/L
Blood transfusion will be administered when the transfusion trigger is met.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Distance walked during 6 minute walk test at 5 weeks postop
Time Frame: 5 weeks
5 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
renal failure, hospital length of stay, Quality of Life questionnaire
Time Frame: during hospital stay
during hospital stay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mary Lee Myers, MD FRCSC, London Health Sciences Centre/University of Western Ontario
  • Principal Investigator: Robin Varghese, MD MS FRCSC, London Health Sciences Centre/University of Western Ontario

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 21, 2004

Primary Completion (Actual)

April 21, 2009

Study Completion (Actual)

February 23, 2010

Study Registration Dates

First Submitted

April 24, 2006

First Submitted That Met QC Criteria

April 24, 2006

First Posted (Estimate)

April 26, 2006

Study Record Updates

Last Update Posted (Actual)

August 28, 2017

Last Update Submitted That Met QC Criteria

August 25, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • R-03-043
  • 9540 (Other Identifier: CTEP)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia

Clinical Trials on Blood Transfusion

3
Subscribe